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ABSTRACT
Many potassium channel families are over-expressed in cancer, but their 
mechanistic role in disease progression is poorly understood. Potassium channels 
modulate membrane potential (V
mem
) and thereby influence calcium ion dynamics and 
other voltage-sensitive signaling mechanisms, potentially acting as transcriptional 
regulators. This study investigated the differential response to over-expression and 
activation of a cancer-associated potassium channel, the intermediate conductance 
calcium-activated potassium channel (IK), on aggressive behaviors in mammary 
epithelial and breast cancer cell lines. IK was over-expressed in the highly metastatic 
breast cancer cell line MDA-MB-231 and the spontaneously immortalized breast 
epithelial cell line MCF-10A, and the effect on cancer-associated behaviors was 
assessed. IK over-expression increased primary tumor growth and metastasis of 
MDA-MB-231 in orthotopic xenografts, demonstrating for the first time in any cancer 
type that increased IK is sufficient to promote cancer aggression. The primary tumors 
had similar vascularization as determined by CD31 staining and similar histological 
characteristics. Interestingly, despite the increased in vivo growth and metastasis, 
neither IK over-expression nor activation with agonist had a significant effect on 
MDA-MB-231 proliferation, invasion, or migration in vitro. In contrast, IK decreased 
MCF-10A proliferation and invasion through Matrigel but had no effect on migration 
in a scratch-wound assay. We conclude that IK activity is sufficient to promote cell 
aggression in vivo. Our data provide novel evidence supporting IK and downstream 
signaling networks as potential targets for cancer therapies.
INTRODUCTION
Breast cancer is one of the most common forms of 
cancer with roughly 230,000 new cases per year and is 
responsible for 40,000 deaths in the United States alone. 
About 1 in every 8 women will be diagnosed with breast 
cancer at some point in her lifetime. Women diagnosed 
with localized breast cancer have an excellent prognosis 
with over 98% 5 year survival. Unfortunately, patients 
with metastases have only a 25.9% 5 year survival 
highlighting the need for treatments aimed at metastasis 
[1]. A major hindrance to the development of better breast 
cancer treatments is a lack of understanding of what drives 
disease progression to metastasis. For decades it has been 
known that some cancers remain in a benign state for long 
time periods while others quickly progress to malignancy, 
and that generally only a subset of tumor cells are 
capable of metastasis. Although many metastasis-specific 
pathways have been described, our understanding of the 
upstream signals that activate these pathways, and the 
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factors that cause certain cells to metastasize while nearby 
syngeneic cells do not, remain largely unknown [2].
Over the past decade ion channels have been 
receiving increased attention for their roles in cancer 
progression. Numerous cancer types have altered ion 
channel expression, with expression of certain channels 
correlating with cancer stage [3]. In various cases, 
inhibiting these channels leads to a decrease in cancer-
associated behaviors including primary tumor growth 
and metastasis in vivo [4–6]. Most studies have focused 
on ion channels as downstream targets of signaling 
pathways that execute critical mechanical functions 
required for aggressive behaviors. For instance, inhibiting 
certain chloride and potassium channels responsible for 
generating changes in cell volume decreases cell migration 
and proliferation [7]. However, evidence suggests ion 
channels may have upstream regulatory roles as well, and 
little is known about the ability of ion channel activity to 
initiate signaling cascades to promote aggressive cancer 
behaviors [8, 9].
The intermediate conductance calcium-activated 
potassium channel (IK) is over-expressed in numerous 
cancer types including breast, prostate, uterus, stomach, 
colorectal, pancreas, pituitary gland, and brain cancers 
[10] and inhibiting IK decreases cancer cell proliferation, 
migration, and in vivo tumor growth and metastasis 
[11–16]. Based on these results, the widely held theory in 
the field is that IK is a downstream effector of signaling 
pathways and is required in the late steps of enacting 
aggressive cancer behaviors. However, IK may have 
additional upstream instructive roles and its activity may 
be sufficient to initiate aggressive behaviors through 
its effect on calcium dynamics. In prostate cancer 
cells, activation of IK with its agonist was sufficient to 
significantly increase intracellular calcium concentrations 
suggesting IK could regulate downstream calcium-
dependent signaling pathways [17]. Furthermore, IK 
activation was sufficient to increase prostate cancer 
proliferation, providing additional evidence of the ability 
of IK to activate signaling pathways [12]. However, the 
possible sufficiency of IK to promote aggressiveness has 
not been previously studied in breast cancer cells.
In the present study, our aims were (1) to investigate 
whether increased IK activity was sufficient to promote 
proliferation in breast epithelial cells and cancer cells 
and (2) to investigate whether an increase in IK was also 
sufficient to increase other aggressive cancer behaviors, 
including tumor growth and metastasis in vivo. We chose 
to use the metastatic breast cancer cell line MDA-MB-231 
because IK inhibition studies demonstrated decreased 
proliferation, migration, and colony formation indicating 
IK has an important physiological role in aggressive 
behaviors in this cell line [18]. Surprisingly, we found 
that MDA-MB-231 in vitro proliferation, invasion, 
and migration were not affected by IK over-expression 
or activation. Interestingly, however, increased IK 
decreased proliferation and invasion of the spontaneously 
immortalized breast epithelial non-tumorigenic MCF-
10A cell line but had no effect on migration. In contrast 
to the in vitro results, we found that over-expressing IK 
in MDA-MB-231 was sufficient to increase primary 
tumor growth and metastasis in mice. This study is the 
first to demonstrate the sufficiency of IK to increase 
cancer aggression in vivo and suggests the possibility of 
key differences in behavioral response to IK activation 
between tumorigenic and non-tumorigenic cells, although 
more cell lines must be tested to determine a potential 
trend. Our results indicate that IK plays an important 
instructive role in cancer progression and suggest the 
possibility of unique signaling mechanisms that could be 
used as specific targets.
RESULTS
IK over-expression increases potassium current 
and hyperpolarizes V
mem
In order to test the sufficiency of increased IK to 
induce increased aggression in the breast cancer cell line 
MDA-MB-231, we first generated cells with increased IK 
expression. Cells were infected by a retrovirus encoding 
either IK and red fluorescent protein (RFP) or RFP alone 
as vector control and selected for RFP using fluorescence 
activated cell sorting (FACS) (Supplementary Figure 
1). MDA MB 231 have previously been reported to 
endogenously express IK [19](data accessible at NCBI 
Geo database GSE41678). We confirmed that IK was 
expressed in control cells (MDA-MB-231-RFP) by RT-
PCR and that cells infected with IK virus (MDA-MB-231-
IK) had significantly increased IK expression (p = 0.0027, 
2-sample t-test, Figure 1A). Overexpression was further 
confirmed at the protein level by immunofluorescence 
(Figure 1B).
To validate functional activity of the over-expressed 
IK channel, the electric current density and V
mem
 of 
individual cells were measured in the presence or absence 
of 200 μM of the IK agonist 1- Ethylbenzimidazolinone 
(1-EBIO). It should be noted that 1-EBIO is also an 
agonist of the closely related small conductance calcium 
activated potassium channels (SK) [20]. However, SK 
transcripts were below the limit of detection using RT-
PCR suggesting that IK is more prevalent. Furthermore, 
treatment of MDA-MB-231 with the IK specific antagonist 
TRAM-34 inhibits most calcium-sensitive potassium 
current indicating that SK has lower endogenous activity 
[18]. Electrophysiological recordings were acquired in 
the cell attached configuration using a perforated patch in 
order to best maintain the endogenous cytosolic contents 
and preserve V
mem
. 1-EBIO treatment had no effect on 
current density of control MDA-MB-231-RFP cells 
(q = 0.15; 1-way ANOVA of 0 mV current density). 
Similarly, IK over-expression had no effect on current 
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density in the absence of 1-EBIO (q = .31; 1-way ANOVA 
of 0 mV current density). However, in MDA-MB-231-IK 
cells, 1-EBIO treatment significantly increased the current 
density from 0.98 ± 2.32 pA/pF to 32.33 ± 13.60 pA/pF (p < 
.001, q = 12.30 1-way ANOVA of 0 mV current density; 
Figure 1C). Furthermore, the current density of MDA-
MB-231-IK treated with 1-EBIO was significantly larger 
than either untreated or 1-EBIO treated control cells (q = 
11.31 and q = 11.14 respectively, 1-way ANOVA of 0 mV 
current density). The reversal potential for MDA-MB-231-
IK EBIO treated cells was -76.21 ± 2.58 mV, relatively near 
the potassium reversal potential predicted by the Nernst 
Figure 1: Functional contribution of IK over-expression to current density and V
mem
. (A) IK mRNA expression levels 
relative to GAPDH in total RNA collected from MDA-MB-231 infected with pMIG-RFP (Cont.) or pMIG-IK (IK) and selected for RFP 
fluorescence by FACS. Data are presented as mean with standard error of the mean (SEM) of 3 independent replicates (** significant 
difference p < 0.01, 2 sample t-test). (B) MDA-MB-231 control or MDA-MB-231-IK were fixed on coverslips and immunofluorescence 
microscopy was performed using antibodies to IK (green) with DAPI (blue) staining of the nuclei. Increased intensity of the green IK 
staining is evident in the MDA-MB-231-IK sample. (C) Endogenous and 1-EBIO induced current-voltage relationship in control and 
IK-expressing cells recorded in the cell attached perforated patch configuration from MDA-MB-231 cells. Data are presented as mean 
± SEM from a minimum of 7 recordings. The current density was significantly increased in MDA-MB-231-IK 1-EBIO treated cells as 
compared to control vehicle treated, control 1-EBIO treated, and MDA-MB-231-IK vehicle treated cells (*** p < 0.001, 1-way ANOVA 
of 0 mV current density) (D) V
mem
 averaged over 20 seconds from recordings of same cells as C. Data points represent individual cells, 
bars show mean with SEM (*** indicates significantly different than vehicle treated control p < .001, 1-way ANOVA). (E) V
mem
 recording 
of representative MDA-MB-231 control cell (top) and MDA-MB-231-IK cell (bottom) with bath solution exchanged to 1-EBIO solution 
beginning at 30 seconds and continuing through duration of recording. There is a ~7 second delay between when the solutions are changed 
and when the new solution reaches the cells.
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equation (-89.9 mV), indicating the current was comprised 
primarily of potassium flux. These data suggest that MDA-
MB-231-IK cells express significantly more functional IK 
channels than control MDA-MB-231-RFP cells.
IK over-expression without agonist treatment did 
not significantly alter the V
mem
 of MDA-MB-231 cells 
(control -26.3 ± 8.2 mV, MDA-MB-231-IK -33.5 ± 16.5 
mV, q = 1.34, 1-way ANOVA). However, there was 
a greater range of V
mem
 values in the MDA-MB-231-
IK population (range of -6.4 to -67.6 mV) compared to 
control cells (range of -13.9 to -40.6 mV; p = 0.045; F 
test to compare variance) with the IK population being 
skewed towards hyperpolarized (control -0.26, MDA-
MB-231-IK -0.62, adjusted Fisher-Pearson standardized 
moment coefficient), suggesting IK over-expression leads 
to increased basal levels of conductance in some cells or 
is transiently active (Figure 1D). Application of 1-EBIO 
significantly hyperpolarized the V
mem
 of MDA-MB-231-
IK cells to -73.9 ± -2.8 mV (p < .001, paired 2-sample 
t-test). 1-EBIO also hyperpolarized the V
mem
 in control 
cells, although this was not statistically significant (-40.3 
± 17.7 mV; p = 0.06 paired 2-sample t-test). Additionally, 
control cells exhibited a fluctuation in V
mem
 at the time of 
1-EBIO application, suggesting the presence of active IK 
or SK channels (Figure 1E).
MDA-MB-231 in vitro proliferation, invasion, 
and migration are unaffected by IK over-
expression and activation
We next investigated the effect of IK expression 
and activity on in vitro behaviors of MDA-MB-231 cells. 
IK is endogenously activated by calcium signaling and 
its activation is highly temporally and spatially regulated 
which may be important to its downstream function [13]. 
We wanted to compare the effect of increased IK current 
responding to endogenous temporal and spatial activation 
as well as to low and high levels of continuous pan-IK 
activation. Cells over-expressing IK were expected to 
maintain endogenous activation patterning but with larger 
currents. We therefore compared the behavioral response 
of control and IK over-expressing cells treated or untreated 
with agonist.
It has been previously reported that IK over-
activation by agonist treatment increases proliferation 
in prostate cancer cells [12]. Here, we monitored the 
proliferation of both control and IK over-expressing 
MDA-MB-231 cells over 4 days in the presence or 
absence of 1-EBIO. We found that there was no significant 
difference in proliferation across any of the conditions 
(Day 4: p = 0.33 1-way ANOVA; Figure 2A). We next 
evaluated in vitro behaviors associated with metastasis. 
The ability of cells to invade was assayed in vitro using 
a transwell assay in which the number of cells invading 
across a Matrigel-coated membrane in response to a 
serum gradient was quantified. There was no significant 
difference in the number of invading cells across any 
of the conditions (p = 0.32 1-way ANOVA; Figure 2B). 
Similarly, migration in a scratch wound assay was not 
altered, with no significant difference in the surface area 
of wound recovery after 10 h (p = 0.41 1-way ANOVA; 
Figure 2C). These results suggest that increased IK 
activity is not sufficient to increase in vitro measures of 
MDA-MB-231 cell aggression.
IK over-expression and activation decreases 
colony formation of MDA-MB-231 Cells
The ability to form colonies in soft agar is used as 
an in vitro measure of transformation and tumor forming 
Figure 2: IK over-expression and activation with 1-EBIO had no effect on MDA-MB-231 proliferation, invasion, or 
migration. (A) Proliferation of control and IK over-expressing MDA-MB-231 cells was quantified over 4 days for cells treated with 
vehicle control or 1-EBIO. There was no significant difference in cell number on any day (Day 4: p = 0.33, 1-way ANOVA). (B) Invasion 
through Matrigel coated transwell after 16 h using FBS as a chemoattractant. Average number of cells per field of view with 4 fields of view 
per sample and 4 replicates in each of 3 independent experiments. There was no significant difference in the number of invading cells across 
any condition (p = 0.32, 1-way ANOVA) (C) A confluent layer of MDA-MB-231 control or MDA-MB-231-IK was scratched and healing 
was assessed after 10 h with vehicle control or 1-EBIO treatment. There was no significant difference in the normalized surface area of 
wound recovery (p = 0.41, 1-way ANOVA). All data presented as mean with SEM of three independent replicates.
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ability. Inducing expression of oncogenes such as c-MYC 
or RAS in non-tumorigenic cell lines can confer colony 
forming ability which correlates with tumor formation 
in mouse xenografts demonstrating the capacity of this 
assay to assess conversion to a malignant phenotype [21]. 
MDA-MB-231 cells are highly malignant and therefore 
readily form colonies. Given that IK is over-expressed 
in many metastatic cancers, we anticipated increased IK 
activity would increase colony formation. Surprisingly, 
colony formation in IK-expressing cells was decreased 
to 64% as compared to untreated control and was 
further decreased to 30% by 1-EBIO treatment (Figure 
3A–3B; p < 0.001 1-way ANOVA). 1-EBIO similarly 
reduced the colony formation of control MDA-MB-231 
cells to 32% of untreated cells. These data suggest that 
treatment with 1-EBIO, which induces constant IK 
activation, more severely inhibits colony formation than 
elevated transiently activated IK induced by increased IK 
expression.
IK activation decreases MCF-10A proliferation 
and invasion
MDA-MB-231 cells are highly aggressive and 
so the lack of effect of IK expression/activity on cell 
proliferation, migration, and invasion may be due to an 
inability to further augment these already aggressive 
behaviors. We therefore tested the effect of increased IK 
expression and activation in the non-tumorigenic breast 
epithelial MCF-10A cell line. We created an IK over-
expressing population of MCF-10A cells. As with MDA-
MB-231, MCF-10A-IK cells had dramatically increased 
IK expression (p < 0.001, 2-sample t-test; Supplementary 
Figure 2A) and increased current density at 0 mV with 
1-EBIO treatment from 0.483 +/- 0.344 pA/pF in control 
cells to 22.90 +/- 18.46 pA/pF in MCF-10A-IK (p < .001, 
q = 7.30 1-way ANOVA, Supplementary Figure 2B). IK 
over-expression without agonist treatment hyperpolarized 
the V
mem
 of MCF-10A cells from -21 ± 6.3 mV in control 
cells to -47 ± 14.7 mV in MCF-10A-IK cells (p < 0.001, 
1-way ANOVA; Supplementary Figure 2C) indicating the 
overexpressed channels were activated by endogenous 
signaling. Application of 1-EBIO hyperpolarized MCF-
10A control cell V
mem
 to -31 ± 7.4 mV (p < 0.01, paired t 
test) indicating that the cells have endogenous IK or SK 
channels. 1-EBIO treatment induced a larger effect on 
MCF-10A-IK cells, hyperpolarizing the V
mem
 to -69 ± 
6.9 mV (p < 0.01, paired t-test). Although the effect of 
1-EBIO treatment may have been partially mediated by 
SK channel activation, we were not able to detect SK 
transcripts by RT-PCR suggesting SK has either very low 
or no expression in MCF-10A cells. In summary, these 
data demonstrate that IK overexpression in MCF-10A 
cells induces a similar change in electrical properties to 
MDA-MB-231 cells.
We next studied the effect of IK expression and 
activity on in vitro measures of aggression in MCF-10A 
cells. IK over-expression alone had no effect on MCF-10A 
cell proliferation, but activation of IK by 1-EBIO treatment 
significantly decreased proliferation of control MCF-10A 
cells by 33 ± 4 % and IK expressing cells by 43 ± 16 % 
(p < 0.01, 1-way ANOVA; Figure 4A). MCF-10A invasion 
was significantly decreased by both IK over-expression 
and activation (p < 0.001, 1-way ANOVA; Figure 4B). 
Figure 3: MDA-MB-231 soft agarose colony formation is decreased by both IK expression and IK activation. (A) Bright 
field images of crystal violet stained MDA-MB-231 control and MDA-MB-231-IK cells grown in soft agarose and treated with vehicle 
control or 1-EBIO for 28 days. (B) Quantification of colonies from A. Data presented as mean with standard deviation of three independent 
replicates, *** indicates significantly different than vehicle treated control, +++ significant difference between indicated samples (p < 0.001 
1-way ANOVA).
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It should be noted that in the control condition, less than 
1% of the cells loaded in the upper chamber invaded to 
the lower chamber reflecting similar basal invasion levels 
as has been reported elsewhere and significantly reduced 
as compared to MDA-MB-231 [22–24]. However, no 
significant change in cell migration using a wound scratch 
assay was observed across any condition (p = 0.28, 1-way 
ANOVA; Figure 4C). Finally, we tested the effect of IK 
expression and activity on colony-forming ability. MCF-
10A is an immortal but not transformed cell line and is 
unable to form colonies in soft agarose but can be induced 
to form colonies by expression of strong oncogenes [25]. 
Neither MCF-10A control nor MCF-10A-IK cells were 
able to form colonies with or without 1-EBIO treatment 
(Supplementary Figure 3).
IK over-activation by 1-EBIO causes MCF-10A 
but not MDA-MB-231 cells to accumulate in G2
We initially hypothesized that the differential 
proliferative response between MCF-10A and MDA-
MB-231 cells was due to a difference in apoptosis 
sensitivity. High potassium currents have been reported 
to induce apoptosis and one possibility was that MCF-
10A cells are sensitive to large potassium currents while 
MDA-MB-231 cells could be protected by anti-apoptotic 
signaling that is often active in highly metastatic cells 
[26]. To test this, we measured the percentage of apoptotic 
and dead cells to determine if the decrease in MCF-
10A cell number following IK activation was due to an 
increase in cell death. Control and IK over-expressing 
cells were cultured for 24 hours in 1-EBIO or vehicle 
control and stained with Annexin-V-FITC, which binds 
external phosphatidylserine an early marker of apoptosis, 
and violet dead cell stain. FACS was used to quantify 
the percentage of labeled cells. There was no significant 
difference in the percentage of apoptotic or dead cells 
across all cell conditions for both MCF-10A and MDA-
MB-231 cells (Figure 5A, 5C). We next investigated 
changes in the cell cycle distribution in the same samples 
using propidium iodide staining. 1-EBIO treatment 
increased the percentage of control and IK-overexpressing 
MCF-10A cells in the G2 phase (from 14.80 ± 3.71 % 
to 18.48 ± 3.27 % in control MCF-10A cells and from 
16.08 ± 2.18 % to 21.4 ± 5.1 % in MCF-10A-IK cells; p < 
0.01, 1-way ANOVA; Figure 5C). However, no significant 
differences were found in any of the conditions for MDA-
MB-231 cells (p = 0.29, 1-way ANOVA; Figure 5D). The 
increased G2 accumulation was therefore observed in the 
same populations that had decreased proliferation. These 
data suggest that in MCF-10A cells the G2/M checkpoint 
includes a requirement for decreased IK activity and/or 
depolarization and that MDA-MB-231 cells are able to 
evade this requirement, possibly due to strong pro-growth 
signaling active in this cell line.
IK expression increases MDA-MB-231 primary 
tumor growth and metastasis
Given the various effects of IK expression and 
activity on cellular aggressiveness in vitro, we next 
assessed the effect of IK over-expression on in vivo 
tumor growth and metastasis. MDA-MB-231 control and 
MDA-MB-231-IK cells were injected into the mammary 
fat pad of 6 wk old female Rag2-/- Il2rg-/- mice. Caliper 
measurements were used to estimate the tumor volume 
over 4 wks of tumor growth. Primary tumor growth 
was significantly increased in MDA-MB-231-IK tumors 
Figure 4: 1-EBIO treatment decreased MCF-10A proliferation and invasion but had no effect on migration. (A) Control 
and IK over-expressing MCF-10A proliferation was quantified over 4 days for cells treated with vehicle control or 1-EBIO (** p < 0.01 
indicates significantly different than vehicle control, 1-way ANOVA). (B) Invasion through Matrigel-coated transwell after 24 h using horse 
serum and EGF as a chemoattractant. Average number of cells per field of view with 4 fields of view per sample and 4 replicates in each of 
3 independent experiments (*** p < 0.001 indicates significantly different than vehicle treated control, +++ p < 0.001 indicates significant 
difference between indicated samples, 1-way ANOVA). (C) A confluent layer of MCF-10A control or MCF-10A-IK was scratched and 
treated with vehicle control or 1-EBIO. Healing was assessed after 12 h by quantifying the surface area of wound recovery (no significant 
difference across all conditions; p = 0.28, 1-way ANOVA). All data presented as mean with SEM of three independent replicates.
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beginning 17 days post cell injection (p < 0.05, 2-sample 
t test; Figure 6A). To demonstrate that the tumors were 
derived from the injected cells, tumor sections were 
stained for human nuclear antigen (HNA) and cells 
stained positively throughout the bulk of the tumor 
(Figure 6B). MDA-MB-231-IK tumors showed higher IK 
immunoreactivity compared to control tumors, suggesting 
that IK over-expression was retained in vivo (Figure 6B). 
Despite the increase in tumor size, there was no significant 
difference in the number of Ki67 positive proliferating 
cells in 28 day tumor sections (p = 0.27, 2-sample t-test; 
Figure 6C). There was also no significant difference 
in the number of cleaved caspase-3 positive apoptotic 
cells in tumor sections at day 28 (p = 0.15, 2-sample 
t-test; Figure 6E). However, there was a trend towards 
increased Ki67+ cells and reduced caspase-3+ cells in 
the IK-overexpressing tumors, suggesting that increased 
proliferation and/or reduced apoptosis may contribute to 
the increased size of these tumors. In addition, as these 
measurements were taken at the end of the experiment, 
they may underestimate a larger difference in proliferation 
or apoptosis that occurred earlier on in the growth of the 
tumor.
We next investigated whether the primary tumors 
also displayed differences in aggressive phenotypes. 
Staining of primary tumor sections with H&E revealed 
Figure 5: 1-EBIO treatment increased G2 phase accumulation in MCF-10A but had no effect on MDA-MB-231. Control 
and IK over-expressing MCF-10A (A) and MDA-MB-231 (C) cells were treated with vehicle control or 1-EBIO for 24 h, stained with 
annexin-FITC and violet dead stain, and analyzed by flow cytometry to quantify the percentage of positively stained cells (no significant 
difference in annexin-V or dead stained cells across any condition, 1-way ANOVA). (B, D) Plot of cell count versus propidium iodide 
(PI) fluorescence to analyze cell cycle. Arrow marks fluorescence intensity corresponding to G2 phase. Plot is representative of three 
independent replicates (MCF-10A **p < 0.01, MDA-MB-231 p = 0.29, 1-way ANOVA). All data presented as mean with SEM of three 
independent replicates.
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similar local invasion into surrounding muscle and 
fibroadipose tissue from both MDA-MB-231 control and 
MDA-MB-231-IK primary tumors (Figure 7A). To assess 
vascular density, primary tumor sections were stained 
with the endothelial marker CD-31 and the number of 
vessels per square millimeter was quantified. There was 
no significant difference in the vascular density between 
control and MDA-MB-231-IK tumors and surprisingly if 
anything there was a trend towards denser vascularization 
in control cells (p = 0.14, 2-sample t-test, Figure 7B).
We also assessed metastatic dissemination by 
comparing the number of cells metastasizing to the 
lung. Lungs were sectioned and stained with anti-
HNA antibody and the number of metastasizing cells 
was quantified. There was a significant increase in the 
number of metastasizing cells/mm2 in MDA-MB-231-IK 
injected mice as compared to control (p < 0.01, 2-sample 
t-test; Figure 8A-8B). In summary, IK over-expression 
significantly increased primary tumor growth as well as 
dissemination of cells to lung tissue.
DISCUSSION
Despite decades of research, metastatic cancer 
continues to have high rates of recurrence and patient 
mortality. A better understanding of the molecular 
pathways that promote aggressive behaviors is needed in 
order to develop treatments aimed at preventing metastasis. 
IK channels play important functions in proliferation, 
migration, and invasion as shown by a decrease in these 
behaviors in vitro and in vivo with IK inhibition or knock-
down [11, 14, 27, 28]. In this study we investigated 
whether IK was also sufficient to promote these behaviors, 
as sufficiency would suggest IK plays important roles in 
upstream signaling pathways driving disease progression. 
We found that over-expression of IK was sufficient to 
increase primary tumor growth and metastasis but that it 
had cell line dependent differential effects on aggressive 
behaviors in vitro. This study adds to data from inhibition 
studies suggesting differences in behavioral response 
to potassium channel activation between cell lines of 
different tumor aggressiveness [15, 29]. Furthermore, there 
was no significant change in MDA-MB-231 proliferation 
in response to IK activation, which is in contrast to the 
previously reported increased proliferation of prostate 
cancer cell lines [12, 17]. These results suggest important 
differences exist in the signaling networks downstream of 
IK activation between different cell lines and support the 
investigation of primary tissue and tumors to determine if 
these differences correlate with disease state.
In support of the initial hypothesis that increased 
IK activity promotes cancer progression, in vivo primary 
tumor growth and metastasis of MDA-MB-231 to the 
lung was increased by IK over-expression. MDA-
MB-231 control and MDA-MB-231-IK cells developed 
similarly aggressive primary tumors with no observable 
difference in local tissue invasion or vascularity. This may 
be because MDA-MB-231 cells are endogenously highly 
invasive and it may be difficult to observe potentiation 
in primary tumors. The in vivo data are in contrast to 
the effect of IK over-expression on in vitro proliferation 
and aggressive behaviors of MDA-MB-231 cells. While 
there was no significant effect of IK on proliferation, 
migration, or invasion, it is interesting to note that there 
was a trend of MDA-MB-231-IK having the highest 
value in each assay. It is possible that IK over-expression 
results in a small increase of each behavior that is 
challenging to detect within the inherent variability of 
the assays. But in vivo where the effect of all of these 
behaviors is combined during tumor growth, the overall 
effect is amplified and becomes statistically significant. 
Alternatively, we speculate the opposing in vitro and 
in vivo results could reflect a requirement for signaling 
from the surrounding tumor microenvironment. It is well 
known that many in vivo factors with important effects 
on cancer cell behavior are not recapitulated in vitro and 
often treatments that reduce aggressive in vitro behaviors 
have no effect in vivo [30–32]. Microenvironmental 
factors that influence IK activation and signaling have not 
been studied extensively and may have important roles. 
For example, growth-promoting effects of IK signaling 
may require highly specialized spatio-temporal activation 
that is not recapitulated in vitro. IK signaling may be 
initiated by interactions with stromal cell types, activation 
of specific adhesion molecules, or microenvironmental 
factors such as hypoxia or inflammatory cytokines, as 
potassium conductance has been shown to be sensitive 
to all of these factors [33, 34]. As a specific example, 
signaling from the human eag-related gene 1 potassium 
channel (hERG1) is dependent on interactions with 
integrin receptors, demonstrating one mechanism by 
which potassium channel activity is linked to a feature 
of the surrounding microenvironment [35, 36]. Further 
experiments are needed to determine how IK activity is 
responsive to microenvironmental factors.
Migration of both MCF-10A and MDA-MB-231 
cells was unaffected by IK over-expression and activation 
suggesting IK activity is insufficient to drive migration. 
Prior studies have reported that IK inhibition decreases 
migration in MDA-MB-231 and have supported a role for 
activation of IK specifically on the lagging edge [13, 18]. 
Activation lacking spatial regulation, such as occurs with 
addition of agonist, may have counteracting effects. The 
effect of increased IK expression on spatially restricted 
activation is not known. Activation of IK has been 
reported to increase intracellular calcium [17], allowing 
for the possibility of a positive feed-back loop whereby 
activation of some channels increases intracellular calcium 
which then activates additional channels. High expression 
of IK could increase positive feedback mechanisms and 
cause spatially restricted signals to be propagated to larger 
portions or the entire cell.
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Figure 6: IK over-expression increases in vivo tumor growth of MDA-MB-231. (A) MDA-MB-231 control (n = 11) and 
MDA-MB-231-IK (n = 9) cells were injected into the inguinal mammary fat pad of 6 wk old female mice and tumor size was plotted over 
time. Data presented as mean with SEM (* p < .05, ** p < .01, ***p < .001 2 sample t-test). (B) Fixed primary tumor sections stained 
with antibody to human nuclear antigen (green) with DAPI (blue) staining of the nuclei (top) or with anti-IK antibody (green; bottom). 
(C) Quantification of Ki67 positive (left) and active Caspase-3 positive (right) cells in primary tumor sections with representative images 
of Ki67 and active caspase-3 (green) staining with DAPI (blue) staining of the nuclei shown below. There was no significant difference in 
the percentage of either Ki67 or active caspase-3 positive cells (p = 0.27, 2-sample t-test and p = 0.15, 2-sample t-test).
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IK expression and activation decreased in vitro 
invasion of MCF-10A but not MDA-MB-231 cells. This 
effect was most pronounced in IK over-expressing cells 
treated with agonist and thus the degree to which MCF-
10A invasion was inhibited correlated with the level of 
IK activity. Given that there was no change in MCF-10A 
migration, the decreased invasion is likely related to 
either an inability to degrade the ECM or dysregulation of 
volume control preventing volume reduction required to 
pass through the pores in the membrane. Further studies 
are needed to distinguish these two possibilities as well 
as to understand why MCF-10A but not MDA-MB-231 
invasion is sensitive to increased IK currents. Surprisingly, 
IK expression and activation decreased MDA-MB-231 
colony formation. Further studies are needed to delineate 
a mechanism for this result.
In contrast to increased proliferation seen in 
prostate cancer cells, neither IK over-expression nor 
activation with 1-EBIO caused a change in MDA-MB-231 
proliferation, suggesting the mechanism downstream of 
IK activation may not be conserved across cancer types 
[12]. Additionally, proliferation of the non-tumorigenic 
cell line MCF-10A was decreased by IK activation in 
both control and IK over-expressing cells but not by IK 
over-expression alone. There was no change in apoptosis 
or cell death suggesting the diminished cell number 
was due to a decrease in the rate of cell division. MCF-
10A control and IK over-expressing cells treated with 
1-EBIO had a significant increase in the percentage of 
cells in G2 while IK over-expression alone had no effect 
on cell cycle distribution. MDA-MB-231, which had 
no change in proliferation across any condition, also 
Figure 7: No evidence of increased aggression in primary tumor. (A) Primary tumor sections stained with H&E. (B) Quantification 
of vessel density in primary tumors (top) with representative CD31 stained sections (bottom, green - CD31, blue - nuclei stained with DAPI; 
p =0.14, 2-sample t-test).
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had no significant difference in the percentage of cells 
in G2. Thus, the accumulation of MCF-10A cells in G2 
mirrored the decrease in proliferation, suggesting constant 
IK activation decreases proliferation of MCF-10A by 
inhibiting progression from G2 to mitosis. Changes in 
potassium channel activity and V
mem
 are associated with 
progression through check points of the cell cycle with 
depolarization and a decrease in potassium channel 
activity typically occuring during G2 [5]. Activation of IK 
may prevent depolarization during late G2 and progression 
to mitosis. Further investigation is needed to determine if 
G2 accumulation is due to hyperpolarization specifically, 
as this would for the first time indicate a requirement for 
depolarization as part of the G2 checkpoint. The different 
response seen between MDA-MB-231 and MCF-10A 
cells suggests the cell lines may have distinct bioelectric 
profiles with altered sensitivity to bioelectric events. 
This may be a result of differences in expression of 
bioelectric sensors including proteins related to calcium 
signaling, or a difference in the ability to compensate 
for the increased potassium current. Understanding the 
bioelectric requirements of the G2 checkpoint may help 
elucidate novel therapies designed to utilize differences in 
sensitivity to target specific cell populations.
One possible mechanism to explain the contrasting 
behavioral response between MCF-10A and MDA-
MB-231 is a difference in expression of IK binding 
partners and other closely associated proteins that differ 
between the two cell types. IK signaling is dependent 
on interactions with beta-1-integrin and TRP member 
calcium channels in other cell types [17, 37]. Little is 
known about variability of associated proteins and how 
it affects behavioral response. There are many members 
within the TRP calcium channel family each with 
unique activation properties and thus IK associated with 
different members may have a different effect on calcium 
Figure 8: IK over-expression increases metastasis to the lung. (A) Quantification of HNA positive cells in lung tissue sections 
collected 4 weeks after mice were injected in the mammary fat pad with MDA-MB-231 cells. Data are mean with SEM of 3 sections per 
mouse control n =8, IK n = 9 p < 0.01, 2-sample t-test). (B) Representative image of HNA staining (green) with DAPI (blue) counterstain 
in full lung section with arrows indicating positive cells.
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dynamics and downstream signaling. While some studies 
have investigated the requirement of associated proteins 
to IK signaling, none have investigated the effect of 
substituting related family members to gauge the response 
to a more subtle perturbation of the system. Additionally, 
a recent study found anomalous downstream responses to 
different IK inhibitors likely caused by maintenance of 
high intracellular calcium in response to one inhibitor but 
not the other [38]. Together with our work, these findings 
suggest the downstream response to IK modulation is 
complex and point to mechanisms that may make the 
response cell-type specific. Analysis of additional cell lines 
and primary cells is needed to determine if the divergent 
behavioral responses to IK stimulation are characteristic 
of specific cell types or disease states and to elucidate the 
mechanism driving the different behaviors.
Prior studies have placed the cancer-associated ion 
channel IK within a growing number of channels that 
are required to support aggressive tumor behaviors. This 
study is the first to demonstrate that IK is also sufficient to 
promote in vivo cancer growth and metastasis. Our findings 
suggest that IK has a greater impact on signaling pathways 
driving cancer progression, likely calcium-sensitive 
pathways, than previously thought. Ion channels are an 
intriguing potential mechanism of metastasis initiation as 
they are highly sensitive to microenvironmental factors 
and therefore could explain why only a small percentage 
of syngeneic cells go on to form metastases. The results of 
this study support the ability of IK to increase aggression 
of already transformed cancer cells. The ability of IK to 
promote tumor growth and metastasis in vivo points to 
the potential of IK-inhibiting drugs to decrease cancer 
progression. Furthermore, the opposing behavioral 
response between cancerous MDA-MB-231 and non-
tumorigenic MCF-10A cell lines warrants further study 
to determine if there are unique mechanisms conferring 
different sensitivities that could be utilized to formulate 
targeted therapies.
MATERIALS AND METHODS
Generation of pMIG expression plasmid
The retroviral expression plasmid pMIG and a 
plasmid containing tagRFP (RFP- red fluorescent protein) 
were purchased from Addgene (#12282 and #37537). 
A plasmid containing the IK complete coding sequence 
was purchased from Genecopoeia (GC-0G00902). The 
IK coding sequence in tandem with P2A and tagRFP 
was inserted into pMIG to replace the IRES and green 
fluorescent protein (GFP) sequence using the Gibson 
cloning method following manufacturer instructions 
(NEB). Briefly, primers were designed to amplify pMIG 
excluding the IRES-GFP sequence (forward primer 5’ 
GCCAAGCTTATCGATAAAATAAAAGA, reverse 
primer 5’ AATTCCGGCGCCTAGAGA). Primers for 
the channels and tagRFP were designed with 15-40 
bp overhanging sequences to match the adjacent DNA 
sequence of the final plasmid and to insert the P2A 
sequence (IK forward primer 5’ CTAGGCGCCGGAATT
ACCATGGGCGGGGATCTGG, reverse primer 5’ TCTC
CTGCTTGCTTTAACAGAGAGAAGTTCGTGGCTCC
GGATCCCTTGGACTGCTGGCTGGG; tagRFP forward 
primer 5’ TCTCTCTGTTAAAGCAAGCAGGAGACGT
GGAAGAAAACCCCGGTCCTGTGTCTAAGGGCGAA 
GAGCTGA, reverse primer 5’ CCTACAGGTGGGGTC
TCACTTGTACAGCTCGTCCATGCC). All fragments 
were amplified by PCR and gel purified. A Gibson 
reaction was performed using three DNA fragments, the 
pMIG backbone, channel, and tagRFP, to create the final 
plasmid (pMIG-IK). A plasmid with only tagRFP inserted 
was generated as a control (pMIG-RFP).
Retrovirus production and transduction
Two days prior to transfection, 2 × 106 293 Plat 
GP cells (Cell Biolabs) were plated on a 10 cm dish. 
Transfection was performed with 60 μL of lipofectamine 
2000, 6 μg of VSV packaging plasmid, and 12 μg of 
pMIG-Channel-P2A-RFP plasmid per manufacturer 
instructions. Cells were incubated in the DNA:liposome 
complex overnight in a final volume of 6 mL. At 72 hours 
post transfection, virus media was collected and filtered 
through a 45 μm filter. Human breast epithelial cell lines 
were transduced by incubating 50% confluent cells with 
virus in media supplemented with 6 μg/mL polybrene for 
24 hours. At 72 hours post-transduction, retrovirus treated 
cells were placed in media containing 50 μg/mL G418 for 
selection. Retrovirus infected cells were expanded for later 
FACS sorting.
Cell cultivation
MCF-10A and MDA-MB-231 cell line were 
purchased directly from ATCC which certified the identity 
of the cell lines by STR analysis and also certified the cell 
lines as pathogen-free. Cells were maintained following 
ATCC recommendations.
IK activation
Cells were treated with 200 µM 1-EBIO diluted 
from a 400 mM 1-EBIO stock solution in dimethyl 
sulfoxide (DMSO) resulting in a final concentration of 
0.05% DMSO in the cell medium. Control samples were 
treated with an equivalent concentration of DMSO as 
vehicle control.
Electrophysiology
Patch clamp recordings were performed in the cell 
attached perforated patch configuration and data were 
recorded with an Axon DigiData 1550 (Axon Instruments) 
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data acquisition system and an Axopatch 200B (Molecular 
Devices) amplifier. Data were low pass filtered at 5 kHz, 
sampled at 50 kHz, and analyzed using pClamp 10 
software (Axon Instruments). Patch pipettes were pulled 
from thin-wall borosilicate glass with a P-97 micropipette 
puller (Sutter Instruments) and fire polished resulting 
in 4-7 MΩ resistance pipettes. Pipettes were filled with 
intracellular electrode solution (5 mM NaCl, 145 mM 
KCl, 2 mM MgCl
2
, 1 mM CaCl
2
, 1.57 mM ethylene 
glycol-bis(2-aminoethylether)-N-N-N’-N’-tetraacetic 
acid (EGTA), 10 mM 4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES), pH adjusted to 7.4 with 1 
M KOH) supplemented with 150 ng/ml Nystatin to induce 
pore formation. Prior to recording, cells plated on glass 
coverslips were perfused with external bath solution (144 
mM NaCl, 5.4 mM KCl, 1 mM MgCl
2
, 2.5 mM CaCl
2
, 
5.6 mM Glucose, 5mM HEPES, adjusted to pH 7.2 with 
1 M NaOH). After initial seal formation, with a minimal 
seal resistance cut off of 1.0 GΩ, perforation was assayed 
by monitoring the capacitive current transient to a 2.5 
mV step with -30 mV holding potential. Recordings were 
acquired once the series resistance was below 75 MΩ. 
V
mem
 recordings were taken for 30 seconds in control 
extracellular solution supplemented with vehicle control 
with no fluid-flow, during 30 seconds of bath exchange 
with the same solution, during 30 seconds of bath 
exchange with bath solution containing 200 uM 1-EBIO, 
and for 30 seconds in 200 µM 1-EBIO with no fluid flow. 
The reported V
mem
 values are the average from the last 
20 seconds recorded in static fluid from each condition. 
For the current-voltage protocol, cells were held at -30 
mV followed by 50 ms test pulses between -120 mV and 
80 mV in 40 mV steps. Current density was calculated 
by dividing the average current during the voltage step 
without leak subtraction by the whole cell capacitance.
RNA isolation, purification, and quantitative 
PCR
RNA was isolated from confluent cells in a 6-well 
plate. Cells were rinsed with PBS and 200 μL RNA-later 
(Ambion) was added before scraping and transferring 
cells to a 1.5 mL tube. RNA was purified using an RNeasy 
mini kit (Qiagen) per manufacturer instructions. The 
concentration of RNA was determined with a NanoDrop 
2000 (Thermo Scientific). Reverse transcription reactions 
were performed with 1 μg of RNA in a 20 μl reaction 
using iScript Reverse Transcription Supermix (Bio-Rad) 
following manufacturer instructions. Transcript expression 
levels were quantified with a Bio-Rad CFX96 Real Time 
System. Reactions were performed in 20 μL using iQ 
SYBR Green Supermix (Bio-Rad) and 40 ng cDNA with 
the following reaction conditions: 95 ° C 10 min, 40 cycles 
of 95° C 30 sec, 58° C 1 minute, 72 C° 1 minute. The 
primers used to amplify an IK fragment were forward 
primer 5’ CTGCTGCGTCTCTACCTGG and reverse 
primer 5’ AGGGTGCGTGTTCATGTAAAG and GAPDH 
was used as the housekeeping gene with forward primer 
5’ TTCGACAGTCAGCCGCATCTTCTT and reverse 
primer 5’ ACCAAATCCGTTGACTCCGACCTT. To 
detect SK and compare to IK expression levels, QPCR 
was performed using Taqman probes (Thermo Scientific) 
for SK, IK, and GAPDH with Taqman universal master 
mix II (Thermo Scientific) following manufacturer’s 
instructions.
Proliferation assay
MCF-10A cells were plated at 7.5 × 103 cells/cm2 
and MDA-MB-231 cells were plated at 1 × 104 cells/
cm2 in 6 well plates. Cells were allowed to attach in 
normal medium for 3 h followed by exchange to media 
supplemented with drug treatment. Cells were trypsinized 
and counted with a TC 10 automated cell counter (BioRad) 
daily for 4 days with a media change after 2 days.
Apoptosis, cell death, and cell cycle analysis
Cells were plated at 5 × 104 cells/cm2 and allowed 
to attach for 3 hours. Medium was exchanged to medium 
supplemented with vehicle or 200 µM 1-EBIO and cells 
were incubated for 24 h. To quantify the percentage of 
apoptotic and dead cells, cells were trypsinized, washed 
in PBS, and incubated in 0.1% Live/Dead Fixable Violet 
Dead Cell stain for 30 min. Cells were washed in Annexin 
V Binding Buffer and incubated in Annexin V conjugated 
to FITC diluted 1:125 in Annexin V Binding Buffer 
(Invitrogen). For cell cycle analysis, cells were fixed in 
70% ethanol and washed in phosphate-buffered saline 
(PBS). Cells were incubated in 50 ng/mL propidium 
iodide (Invitrogen), 250 ng/mL RNase diluted in PBS 
for 1hr. Cell fluorescence was detected using an LSR II 
(Becton Dickenson) fluorescent cell analyzer and data 
were analyzed with FlowJo software.
Migration assay
MDA-MB-231 cells were plated at 2.5 × 105 cells/
cm2 in a 24 well plate and were serum starved in 1% FBS 
media overnight. A scratch was made with a yellow tip 
and medium was exchanged with low serum medium 
containing drug treatment. Phase contrast images were 
acquired of the initial scratch. 10 h post scratch, cells 
were incubated in 0.5 µg/mL calcein AM for 15 minutes 
and fluorescent images were acquired. ImageJ was used 
to calculate wound healing by first manually outlining the 
wound at time 0 hr to create a region of interest (ROI). 
The fluorescent 10 h image of calcein AM stained cells 
was converted to a binary image such that white pixels 
corresponded to the surface area covered by cells. The 
percentage of white pixels within the initial wound ROI 
was quantified to measure wound healing. Scratch assays 
with MF-10A cells were performed similarly but 24-well 
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plates were seeded with 3.75 × 105 cells/cm2 cells, low 
serum medium consisted of normal MCF-10A medium 
with 0.5% horse serum and 2 ng/mL EGF, and bright field 
images were acquired 0 h and 12 h after scratching and 
the area of the scratch wound was measured with image J.
Invasion assay
The day prior to invasion assays, cells were placed 
in low serum medium. Basement membrane coated 
transwells with 6.5 mm diameter and 8 μm pore size (BD 
Biosciences) were pre-incubated with 500 μL DMEM in 
the upper chamber for 2 hours. MDA-MB-231 cells were 
diluted to 2.5 × 105 cells/mL and MCF-10A cells were 
diluted to 5 × 105 cells/mL in low serum media and 200 
μL of the cell suspension was placed in the upper chamber 
giving 5 × 104 and 1 × 105 cells per well respectively. The 
bottom chamber was filled with 600 μL of normal full 
serum media as a chemoattractant. After 16 h for MDA-
MB-231 cells or 24 h for MCF-10A cells, transwells were 
rinsed in PBS and cells were scraped off of the upper 
chamber. Remaining cells were fixed in 4% PFA for 10 
minutes. Transwells were rinsed in PBS and stained with 
1 μg/mL 4’, 6-Diamidino-2-Phenylindole Dihydrochloride 
(DAPI) for 10 minutes. The number of invading cells was 
counted in 4 fields of view for each sample.
Colony formation assay
MCF-10A cells were plated at 3 × 104 cells per 
well and MDA-MB-231 were plated at 5 × 103 cells per 
well of a six well plate. The wells were first coated in 
1.5 mL of 0.8% agarose diluted in normal culture media. 
Cells were plated in 1.5 mL of 0.4% agarose diluted in 
normal culture media and the agarose was allowed to 
set at room temperature for 1 hr. Samples were cultured 
for 4 weeks with 0.5 mL culture media added on top of 
the culture media with media exchanges every 2-3 days. 
After 4 weeks, samples were fixed in 10% formalin for 
30 minutes and incubated in .005% crystal violet for 1 hr. 
Samples were rinsed in water until the washes were clear 
of stain. Images were acquired using a ChemiDoc XRS+ 
gel imager (BioRad) and associated software. Colonies 
were counted using ImageJ.
Orthotopic breast tumor model
All procedures involving animals were approved by 
the University of York Ethical Review Process and under 
the authority of a UK Home Office project License. Six 
week old female Rag2-/-, Il2rg-/- mice (Yorkshire Cancer 
Research Unit, University of York) were selected at 
random for MDA-MB-231 control or MDA-MB-231-IK 
injection. A 5 × 105 cell suspension was prepared in 20% 
v/v matrigel in saline and injected into the left inguinal 
mammary fat pad of isoflurane anaesthetized mice. A 
total of 14 and 11 mice were injected with MDA-MB-231 
control and MDA-MB-231-IK cells respectively across 
4 independent experiments. Tumors did not take in 3 of 
the control and 2 of the IK expressing mice and were not 
included in analysis giving n = 11 for MDA-MB-231 
control and n = 9 for MDA-MB-231-IK. The length and 
width of primary tumors was measured daily with calipers 
and the tumor volume was calculated as 0.5 × (length × 
width2). Mice were euthanized 28 days after injection and 
tumors and lungs were fixed in 4% paraformaldehyde and 
frozen.
Immunohistochemistry
H&E staining and immunohistochemistry were 
performed as described [39]. The following primary 
antibodies were used: mouse anti-IK (1:20; Alomone); 
rabbit anti-Ki67 (1:5000; Abcam); rabbit anti-activated 
caspase-3 (1:200; R&D Systems); rabbit anti-CD31 (Santa 
Cruz Biotechnology); mouse anti-HNA (1:100; Millipore). 
Secondary antibodies were Alexa-488-conjugated goat 
anti mouse/rabbit (1:500; Invitrogen). Samples were 
mounted in Prolong Gold with DAPI (Invitrogen). 
Sections were scanned at 20X using a Zeiss AxioScan.
Z1 slide scanner. Images were exported into ImageJ for 
processing. Brightness/contrast was adjusted using the 
ImageJ “Auto” function. Density of Ki67+ or activated 
caspase-3+ cells, CD31+ vessel structures, and metastasis 
to lungs were measured across scanned images of whole 
sections, blinded to treatment [39, 40].
Statistics
Statistics were analyzed in Prism 5 and significance 
was determined using a two sample t-test or a one-way 
ANOVA followed by either a Dunett post test (to compare 
multiple conditions to a single control) or a Tukey post 
test (for a comparison of all conditions), alpha = 0.05. 
In cases where a comparison is made between two 
specific conditions from within an ANOVA the q value 
is given, otherwise only the p-value is given. All results 
are presented as mean with standard deviation from 3 
independent experiments unless otherwise noted.
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FBS – fetal bovine serum
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